Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The relationship between metastasis-associated protein 2 (MTA2) overexpression and tumor growth and metastasis has been extensively studied in a variety of tumor cells but not in human osteosarcoma cells. This study aims to elucidate the clinical significance, underlying molecular mechanisms, and biological functions of MTA2 in human osteosarcoma and . Our results show that MTA2 was elevated in osteosarcoma cell lines and osteosarcoma tissues and was associated with tumor stage and overall survival of osteosarcoma patients. Knockdown of MTA2 inhibited osteosarcoma cell migration and invasion by reducing the expression of urokinase-type plasminogen activator (uPA). Bioinformatic analysis demonstrated that high levels of uPA in human osteosarcoma tissues correlated positively with MTA2 expression. Furthermore, treatment with recombinant human uPA (Rh-uPA) caused significant restoration of OS cell migration and invasion in MTA2 knockdown osteosarcoma cells. We found that ERK1/2 depletion increased the expression of uPA, facilitating osteosarcoma cell migration and invasion. Finally, MTA2 depletion significantly reduced tumor metastasis and the formation of lung nodules . Overall, our study suggests that MTA2 knockdown suppresses osteosarcoma cell metastasis by decreasing uPA expression via ERK signaling. This finding provides new insight into potential treatment strategies against osteosarcoma metastasis by targeting MTA2.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11424574 | PMC |
| http://dx.doi.org/10.18632/aging.206070 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
LDH-chitosan bionanocomposites for oncologic applications: A refreshing perspective on the mutual influence through intermolecular forces toward controlled morphology and dispersion.
Int J Biol Macromol
September 2025
Nanotechnology Laboratory, TRANSCEND Research Center, Regional Institute of Oncology, 2-4 General Henri Mathias Berthelot Street, 700483, Iași, Romania; Faculty of Chemistry, Al. I. Cuza University, 11- Carol I Bvd., 700506, Iasi, Romania. Electronic address:
This contribution discusses the design of bionanocomposites based on chitosan and MgAl layered double hydroxides (LDH) for cancer therapy. Compared to other studies, our approach was to pre-adsorb the metal chloride precursors of LDH on chitosan while the solution of metal precursors with and without H provided the acidic environment for polymer dissolution. The structure, morphology and chemical composition of the bionanocomposites were characterized by XRD, FTIR, TG, etc.
View Article and Find Full Text PDFPLEKHF1 Induces Mitochondrial Dysfunction to Inhibit Osteosarcoma Growth and Metastasis.
IUBMB Life
September 2025
Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Osteosarcoma (OS) is an uncommon malignancy with stagnant survival rates over the past four decades and early-stage metastasis, predominantly affecting children and adolescents. This study identified significant metabolic differences between metastatic and non-metastatic OS samples through bioinformatics analysis, highlighting key processes such as cell proliferation, mitochondrial assembly, and changes in mitochondrial membrane permeability. Among differentially expressed genes, Pleckstrin Homology And FYVE Domain Containing 1 (PLEKHF1) was the most significantly downregulated in metastatic OS samples.
View Article and Find Full Text PDFThe malignant dialogue between cancer-associated fibroblasts and osteosarcoma cells: microenvironment-mediated drug resistance and therapeutic targets.
Front Immunol
September 2025
Department of Emergency and Critical Care, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China.
Cancer-associated fibroblasts (CAFs) are pivotal in shaping the immunosuppressive and chemoresistant tumor microenvironment (TME) of osteosarcoma (OS). This review explores how CAFs drive OS progression through paracrine signaling (e.g.
View Article and Find Full Text PDFTargeted Inhibition of NOTCH2 and Importin-β Promotes Osteogenic Differentiation of Osteosarcoma Cells.
Drug Dev Res
September 2025
Department of Orthopedics, Gaoxin Branch of The First Affiliated Hospital, Nanchang University, Nanchang, PR China.
Osteosarcoma (OS) is a common malignant bone tumor, frequently associated with impaired osteogenic differentiation of tumor cells. Recent studies have suggested that the NOTCH signaling pathway plays a crucial role in maintaining tumor cell stemness and may influence their differentiation status. This study investigates the role of NOTCH2, a key receptor in the NOTCH family, in regulating osteogenic differentiation in OS.
View Article and Find Full Text PDFDramatic multifocal osteosarcoma treatment response in the setting of POT1 tumor predisposition syndrome.
Cancer Genet
August 2025
Cincinnati Children's Hospital Medical Center, Division of Oncology, Cincinnati, OH, USA; University of Cincinnati College of Medicine, Cincinnati, OH, USA. Electronic address:
Introduction: POT1 tumor predisposition (POT1-TPD) is associated with a spectrum of malignancies due to loss of function mutations in POT1 leading to telomere elongation and genomic instability. Osteosarcoma is the most common primary malignant bone tumor and has a poor prognosis when multifocal.
Case Presentation: A 15-year-old male was found to have a primary right distal femur osteosarcoma with multiple additional bony sites of disease.